Experience With the Use of Paromomycin Via Nasogastric Tube as Treatment for Cryptosporidium Infection: A Case Report

Iván Cores Rodríguez1, Eduardo Tejedor Tejada1, Daniel Ortiz Del Olmo1

  • 1Segovia Hospital Complex, Segovia, Spain.

Hospital Pharmacy
|December 2, 2024
PubMed

Insights

Cryptosporidiosis, an intestinal infection, is treated with supportive care and drugs like paromomycin. This study explores an extemporaneous paromomycin solution for treating this parasitic infection, especially in vulnerable patients.

Area of Science:

  • Infectious Diseases
  • Parasitology
  • Gastroenterology

Background:

  • Cryptosporidiosis is a significant gastrointestinal illness caused by Cryptosporidium parasites.
  • Transmission occurs through the fecal-oral route, often via contaminated water or food.
  • Immunocompromised individuals face severe and prolonged cryptosporidiosis, with a high risk of recurrence.

Observation:

  • Existing treatments include supportive care and antiparasitic drugs like nitazoxanide and paromomycin.
  • There is a lack of evidence for nasogastric tube administration of paromomycin.
  • This study details the use of an extemporaneous paromomycin solution and its clinical outcomes.

Findings:

  • The study evaluates the efficacy and impact of a custom-prepared paromomycin solution.
  • Clinical data on the use of this specific formulation are presented.
  • The findings address a gap in treatment options for cryptosporidiosis.

Implications:

  • This research may offer a new therapeutic approach for cryptosporidiosis management.
  • The findings could guide the development of alternative drug delivery methods.
  • Further investigation into extemporaneous formulations could improve patient care for parasitic infections.